<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://drugtopics.modernmedicine.com/drugtopics/servlet/drugtopics_47453.rss?id=47453">
    <title>Drug Topics - Clinical News</title>

    <link>http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/Article/list/47453</link>

    <description>For pharmacists, from &lt;em&gt;Drug Topics&lt;/em&gt;: News and features for pharmacists about
    clinical trials, newly approved drugs, and new practices in clinical pharmacy</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Improved-medication-adherence-A-growing-movement-i/ArticleStandard/Article/detail/772757?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Helping-patients-with-diabetes-and-visual-or-manua/ArticleStandard/Article/detail/772750?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-CADACS-antiplatelet-agents-a-mixed-bag/ArticleStandard/Article/detail/772748?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-CF-treatment/ArticleStandard/Article/detail/772756?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Project-RED-pharmacists-reconcile-meds-lower-patie/ArticleStandard/Article/detail/772745?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/CME+Showcase/Helping-your-patients-control-persistent-asthma/CME/Article/detail/772923?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Trial-Surgery-and-therapy-improve-type-2-diabetes/ArticleStandard/Article/detail/772855?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-compares-infection-risk-for-JIA-ADHD-patient/ArticleStandard/Article/detail/772854?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Improvements-in-warfarin-therapy-reduce-stroke-rat/ArticleStandard/Article/detail/771862?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/High-uric-acid-increases-risk-of-high-blood-pressu/ArticleStandard/Article/detail/771861?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Omega-3-shows-no-benefit-for-multiple-sclerosis-st/ArticleStandard/Article/detail/771867?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Debate-Should-healthy-men-with-elevated-cholestero/ArticleStandard/Article/detail/771860?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-links-phthalates-to-type-2-diabetes-in-elder/ArticleStandard/Article/detail/771868?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/11-recommendations-reported-for-arthritis-pain-man/ArticleStandard/Article/detail/771866?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Lower-rates-of-intracranial-hemorrhage-seen-with-P/ArticleStandard/Article/detail/770768?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/The+Latest/Novartis-updates-Gilenya-label-to-include-stronger/ArticleStandard/Article/detail/770531?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-EASD-issue-joint-position-statement-on-hypergl/ArticleStandard/Article/detail/770069?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-approves-pregnancy-category-change-for-insulin/ArticleStandard/Article/detail/769828?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Fibromyalgia-patients-taking-pregabalin-see-/ArticleStandard/Article/detail/769829?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Periprocedural-dabigatran-use-is-associated-with-h/ArticleStandard/Article/detail/769827?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/CDC-calls-for-better-stewardship-to-combat-iC-diff/ArticleStandard/Article/detail/769643?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Associations/New-AHA-guidelines-help-manage-hypertension-in-the/ArticleStandard/Article/detail/769654?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-dabigatran-safety-concerns/ArticleStandard/Article/detail/769651?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Helping-patients-with-diabetes-and-visual-or-manua/ArticleStandard/Article/detail/769639?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Kansas-launches-remote-supervision-for-hospital-ph/ArticleStandard/Article/detail/769641?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Better-clinical-decision-support-improves-CPOE-eff/ArticleStandard/Article/detail/769640?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-treatments-available-for-actinic-keratosis-met/ArticleStandard/Article/detail/769638?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacist-led-interventions-reduced-prescribing-e/ArticleStandard/Article/detail/769652?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-shows-link-between-greater-cost-sharing-and-/ArticleStandard/Article/detail/768796?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Two-antidepressants-decrease-depression-in-Parkins/ArticleStandard/Article/detail/768795?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Fluoroquinolones-may-increase-risk-of-retinal-deta/ArticleStandard/Article/detail/768794?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-updates-drospirenone-containing-birth-control-/ArticleStandard/Article/detail/768692?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/CMS-announces-the-formation-of-27-ACOs-serving-375/ArticleStandard/Article/detail/768468?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/FDA/Label-change-of-liraglutide-demonstrates-superiori/ArticleStandard/Article/detail/768397?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/FDA/Basal-insulin-approved-for-pregnant-women/ArticleStandard/Article/detail/768311?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Rivaroxaban-as-effective-as-standard-therapy-for-t/ArticleStandard/Article/detail/767790?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-guidelines-Dont-treat-most-sinus-infections-wi/ArticleStandard/Article/detail/767788?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Blood-pressure-drug-might-curb-PTSD-related-nightm/ArticleStandard/Article/detail/767786?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Rituximab-may-be-better-second-line-RA-therapy-whe/ArticleStandard/Article/detail/767787?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Risk-of-secondary-cases-of-iC-difficilei-in-househ/ArticleStandard/Article/detail/767789?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Antioxidants-may-not-benefit-patients-with-Alzheim/ArticleStandard/Article/detail/766472?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/3-studies-find-aspirin-reduces-risk-of-cancer-deat/ArticleStandard/Article/detail/766470?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-adds-new-label-warnings-for-the-antidepressant/ArticleStandard/Article/detail/766419?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-once-monthly-treatment-for-anemic-adu/ArticleStandard/Article/detail/766235?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Alzheimers-drugs-donepezil-memantine-show-some-ben/ArticleStandard/Article/detail/765556?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-highlights-need-to-treat-nursing-home-patien/ArticleStandard/Article/detail/765559?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Heroin-may-be-more-effective-than-methadone-for-re/ArticleStandard/Article/detail/765557?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Ingenol-mebutate-gel-is-effective-treatment-for-ac/ArticleStandard/Article/detail/765558?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-drug-for-myelofibrosis/ArticleStandard/Article/detail/764136?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Not-all-omega-3-fish-oils-are-equal/ArticleStandard/Article/detail/764145?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-oral-contraceptive-to-treat-hea/ArticleStandard/Article/detail/764751?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Anticoagulation-may-be-safe-for-many-outpatient-pr/ArticleStandard/Article/detail/764155?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Adding-prednisone-to-treatment-improves-rheu/ArticleStandard/Article/detail/764662?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Aspirin-may-reduce-incidence-of-strokes-in-postmen/ArticleStandard/Article/detail/764663?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacogenomics-and-practical-applications/ArticleStandard/Article/detail/764147?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-effervescent-osteoporosis-treat/ArticleStandard/Article/detail/764690?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-generic-Lexapro-to-treat-depres/ArticleStandard/Article/detail/764666?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Bevacizumab-an-effective-treat-and-extend-regimen-/ArticleStandard/Article/detail/763746?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-panel-recommends-approval-of-aclidinium-bromid/ArticleStandard/Article/detail/763744?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/AAP-now-recommends-HPV-vaccine-for-boys/ArticleStandard/Article/detail/763742?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-warning-Co-administration-of-statins-and-prote/ArticleStandard/Article/detail/762965?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/The+Latest/FDA-approves-first-4-strain-flu-vaccine/ArticleStandard/Article/detail/762697?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-approves-2-pancreatic-enzyme-products-to-aid-f/ArticleStandard/Article/detail/762777?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-IM-injections-more-effective-than-IVs-for-st/ArticleStandard/Article/detail/762519?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Acellular-pertussis-vaccinations-increase-risk-of-/ArticleStandard/Article/detail/762517?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/The+Latest/FDA-warns-of-potential-diabetes-risk-cognitive-adv/ArticleStandard/Article/detail/762396?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/ACIP-expands-recommendations-for-whooping-cough-va/ArticleStandard/Article/detail/761590?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Most-cases-of-CDI-arent-being-spread-by-pati/ArticleStandard/Article/detail/761454?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Antibiotic-amoxicillin-no-help-in-treating-acute-r/ArticleStandard/Article/detail/761452?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Zinc-plus-antibiotics-saves-lives-of-children-with/ArticleStandard/Article/detail/761455?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/No-benefit-of-B-vitamins-or-omega-3-on-cancer-outc/ArticleStandard/Article/detail/761453?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/RxIMPACT-Day-an-opportunity-for-pharmacists-to-spe/ArticleStandard/Article/detail/759140?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/California-regulates-OTC-cough-and-cold-products-t/ArticleStandard/Article/detail/759143?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-acts-to-bolster-supply-of-critically-needed-ca/ArticleStandard/Article/detail/761240?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/NCPA-NACDS-protest-TRICARE-limitations-in-Obama-bu/ArticleStandard/Article/detail/759139?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Whatrsquos-new-on-the-shelves/ArticleStandard/Article/detail/759141?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/AACP-joins-with-healthcare-professions-to-improve-/ArticleStandard/Article/detail/759142?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Georgia-voters-strongly-oppose-mandatory-mail-orde/ArticleStandard/Article/detail/759138?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/First-medication-approved-by-FDA-for-patients-with/ArticleStandard/Article/detail/761113?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/DEA-holding-Pharmacy-Diversion-Awareness-Conferenc/ArticleStandard/Article/detail/759144?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-finds-association-between-open-angle-glaucom/ArticleStandard/Article/detail/759019?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Poorly-controlled-diabetes-may-lead-to-hearing-los/ArticleStandard/Article/detail/759017?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-therapies-for-AMD-insomnia/ArticleStandard/Article/detail/758547?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/More-stroke-patients-going-home-on-anticoagulants/ArticleStandard/Article/detail/758550?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-warning-Counterfeit-version-of-cancer-drug-Ava/ArticleStandard/Article/detail/758923?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-preservative-free-solution-for-glauco/ArticleStandard/Article/detail/758724?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-grants-priority-review-to-GI-agent-for-control/ArticleStandard/Article/detail/758084?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-extended-release-tablets-for-type-2-d/ArticleStandard/Article/detail/757733?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-ivacaftor-to-treat-rare-form-of-cysti/ArticleStandard/Article/detail/757493?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Review-raises-questions-about-why-government-stock/ArticleStandard/Article/detail/757338?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Blood-clots-likely-for-as-many-as-1-in-100-f/ArticleStandard/Article/detail/757108?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/FDA/Ranbaxy-accepts-consent-decree-permanent-injunctio/ArticleStandard/Article/detail/757134?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Anti-infective-drug-shortages-affect-clinical-care/ArticleStandard/Article/detail/757111?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Use-of-aspirin-questioned-as-primary-prevention-fo/ArticleStandard/Article/detail/757112?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-guidelines-recommend-blood-glucose-testing-for/ArticleStandard/Article/detail/757109?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Anti-infective-drug-shortages-affect-clinica/ArticleStandard/Article/detail/756882?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Remington-Honor-Medal-to-go-to-director-of-St-Jude/ArticleStandard/Article/detail/756888?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/ACP-Foundation-hopes-tools-can-help-prevent-stroke/ArticleStandard/Article/detail/756628?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Varicella-vaccination-program-cuts-infection-rate-/ArticleStandard/Article/detail/756629?contextCategoryId=47453&amp;ref=25" />

        <rdf:li
        resource="http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-data-ADT-does-not-increase-cardiovascular-deat/ArticleStandard/Article/detail/756630?contextCategoryId=47453&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2012-05-16T23:43:50Z</dc:date>
  </channel>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Improved-medication-adherence-A-growing-movement-i/ArticleStandard/Article/detail/772757?contextCategoryId=47453&amp;ref=25">

    <title>Improved medication adherence: A growing movement in search of a leader</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Improved-medication-adherence-A-growing-movement-i/ArticleStandard/Article/detail/772757?contextCategoryId=47453&amp;ref=25</link>

    <description>There are many forces in play that can and should &amp;#34;converge to support better medication
    management and improved adherence,&amp;#34; according to Tom Hubbard of the New England Healthcare Institute
    (NEHI), but coordination and leadership will be crucial.</description>

    <dc:date>2012-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772757null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Helping-patients-with-diabetes-and-visual-or-manua/ArticleStandard/Article/detail/772750?contextCategoryId=47453&amp;ref=25">

    <title>Helping patients with diabetes and visual or manual impairment (part 2): Medication administration</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Helping-patients-with-diabetes-and-visual-or-manua/ArticleStandard/Article/detail/772750?contextCategoryId=47453&amp;ref=25</link>

    <description>Part 2 of this article discusses assistive devices that help impaired diabetes patients
    self-administer medication.</description>

    <dc:date>2012-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772750/Pg47_195x210px_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-CADACS-antiplatelet-agents-a-mixed-bag/ArticleStandard/Article/detail/772748?contextCategoryId=47453&amp;ref=25">

    <title>New CAD/ACS antiplatelet agents a mixed bag</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-CADACS-antiplatelet-agents-a-mixed-bag/ArticleStandard/Article/detail/772748?contextCategoryId=47453&amp;ref=25</link>

    <description>New CAD/ACS antiplatelet agents a mixed bag.</description>

    <dc:date>2012-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772748null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-CF-treatment/ArticleStandard/Article/detail/772756?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves CF treatment</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-CF-treatment/ArticleStandard/Article/detail/772756?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approves Ivacaftor and Exenatide extended-release injection.</description>

    <dc:date>2012-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772756null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Project-RED-pharmacists-reconcile-meds-lower-patie/ArticleStandard/Article/detail/772745?contextCategoryId=47453&amp;ref=25">

    <title>Project RED pharmacists reconcile meds, lower patient hospital return rate</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Project-RED-pharmacists-reconcile-meds-lower-patie/ArticleStandard/Article/detail/772745?contextCategoryId=47453&amp;ref=25</link>

    <description>The readmission rate for congestive heart failure patients was reduced by more than 50% after Morris
    Hospital in Morris, Ill., implemented a pilot medication reconciliation program.</description>

    <dc:date>2012-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772745null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/CME+Showcase/Helping-your-patients-control-persistent-asthma/CME/Article/detail/772923?contextCategoryId=47453&amp;ref=25">

    <title>Helping your patients control persistent asthma</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/CME+Showcase/Helping-your-patients-control-persistent-asthma/CME/Article/detail/772923?contextCategoryId=47453&amp;ref=25</link>

    <description>Goal: To assist pharmacists and pharmacy technicians to help patients effectively control persistent
    asthma</description>

    <dc:date>2012-05-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/cme/drugtopics/192012/772923/195x210px_CE_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Trial-Surgery-and-therapy-improve-type-2-diabetes/ArticleStandard/Article/detail/772855?contextCategoryId=47453&amp;ref=25">

    <title>Trial: Surgery and therapy improve type 2 diabetes</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Trial-Surgery-and-therapy-improve-type-2-diabetes/ArticleStandard/Article/detail/772855?contextCategoryId=47453&amp;ref=25</link>

    <description>Bariatric surgery plus medical therapy may be a useful strategy for managing uncontrolled diabetes,
    according to the results of a recent study published in the New England Journal of Medicine.</description>

    <dc:date>2012-05-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772855null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-compares-infection-risk-for-JIA-ADHD-patient/ArticleStandard/Article/detail/772854?contextCategoryId=47453&amp;ref=25">

    <title>Study compares infection risk for JIA, ADHD patients</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-compares-infection-risk-for-JIA-ADHD-patient/ArticleStandard/Article/detail/772854?contextCategoryId=47453&amp;ref=25</link>

    <description>Children with juvenile idiopathic arthritis were at twice the risk of infection compared with children
    with attention-deficit hyperactivity disorder, according to a study published May 1 in Arthritis &amp;amp;amp;
    Rheumatism.</description>

    <dc:date>2012-05-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/192012/772854null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Improvements-in-warfarin-therapy-reduce-stroke-rat/ArticleStandard/Article/detail/771862?contextCategoryId=47453&amp;ref=25">

    <title>Improvements in warfarin therapy reduce stroke rate, study shows</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Improvements-in-warfarin-therapy-reduce-stroke-rat/ArticleStandard/Article/detail/771862?contextCategoryId=47453&amp;ref=25</link>

    <description>Current use of warfarin as a stroke prevention therapy in patients with nonvalvular atrial
    fibrillation is associated with a lower rate of residual stroke or systemic embolism compared with previous data,
    according to a recent study.</description>

    <dc:date>2012-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182012/771862null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/High-uric-acid-increases-risk-of-high-blood-pressu/ArticleStandard/Article/detail/771861?contextCategoryId=47453&amp;ref=25">

    <title>High uric acid increases risk of high blood pressure in teens</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/High-uric-acid-increases-risk-of-high-blood-pressu/ArticleStandard/Article/detail/771861?contextCategoryId=47453&amp;ref=25</link>

    <description>Teenagers with high levels of uric acid have an increased risk for high blood pressure, according to a
    new study published in the April 2012 issue of the journal Hypertension.</description>

    <dc:date>2012-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182012/771861null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Omega-3-shows-no-benefit-for-multiple-sclerosis-st/ArticleStandard/Article/detail/771867?contextCategoryId=47453&amp;ref=25">

    <title>Omega-3 shows no benefit for multiple sclerosis, study finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Omega-3-shows-no-benefit-for-multiple-sclerosis-st/ArticleStandard/Article/detail/771867?contextCategoryId=47453&amp;ref=25</link>

    <description>The supplementation with omega-3 fatty acids has no benefit in treating multiple sclerosis, according
    to a clinical trial that appeared in the JAMA's Archives of Neurology. However, researchers acknowledged the
    randomized controlled trial was underpowered.</description>

    <dc:date>2012-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182012/771867null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Debate-Should-healthy-men-with-elevated-cholestero/ArticleStandard/Article/detail/771860?contextCategoryId=47453&amp;ref=25">

    <title>Debate: Should healthy men with elevated cholesterol levels take statins?</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Debate-Should-healthy-men-with-elevated-cholestero/ArticleStandard/Article/detail/771860?contextCategoryId=47453&amp;ref=25</link>

    <description>Doctors debate whether men with elevated cholesterol who are otherwise healthy should still take
    statins, in a new series in JAMA, Dueling Viewpoints.</description>

    <dc:date>2012-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182012/771860null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-links-phthalates-to-type-2-diabetes-in-elder/ArticleStandard/Article/detail/771868?contextCategoryId=47453&amp;ref=25">

    <title>Study links phthalates to type 2 diabetes in elderly</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-links-phthalates-to-type-2-diabetes-in-elder/ArticleStandard/Article/detail/771868?contextCategoryId=47453&amp;ref=25</link>

    <description>Phthalate metabolites, chemicals commonly used in plastics, cosmetics, and pharmaceuticals, were
    linked to an increased risk for the development of type 2 diabetes in the elderly, a recent study
    found.</description>

    <dc:date>2012-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182012/771868null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/11-recommendations-reported-for-arthritis-pain-man/ArticleStandard/Article/detail/771866?contextCategoryId=47453&amp;ref=25">

    <title>11 recommendations reported for arthritis pain management</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/11-recommendations-reported-for-arthritis-pain-man/ArticleStandard/Article/detail/771866?contextCategoryId=47453&amp;ref=25</link>

    <description>A set of 11 evidence-based recommendations for managing pain with pharmacotherapy in patients
    suffering inflammatory arthritis were reported by an international panel online March 24 in
    Rheumatology.</description>

    <dc:date>2012-05-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/182012/771866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Lower-rates-of-intracranial-hemorrhage-seen-with-P/ArticleStandard/Article/detail/770768?contextCategoryId=47453&amp;ref=25">

    <title>Lower rates of intracranial hemorrhage seen with Pradaxa</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Lower-rates-of-intracranial-hemorrhage-seen-with-P/ArticleStandard/Article/detail/770768?contextCategoryId=47453&amp;ref=25</link>

    <description>Twice-daily dabigatran etexilate mesylate (Pradaxa, Boehringer Ingleheim) was shown to be associated
    with lower rates of fatal and traumatic intracranial hemorrhage compared with warfarin, according to a
    retrospective subanalysis published online, April 5, in Stroke, the Journal of the American Heart
    Association.</description>

    <dc:date>2012-04-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/172012/770768null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/The+Latest/Novartis-updates-Gilenya-label-to-include-stronger/ArticleStandard/Article/detail/770531?contextCategoryId=47453&amp;ref=25">

    <title>Novartis updates Gilenya label to include stronger cardiac warnings after FDA review</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/The+Latest/Novartis-updates-Gilenya-label-to-include-stronger/ArticleStandard/Article/detail/770531?contextCategoryId=47453&amp;ref=25</link>

    <description>Novartis has agreed with FDA to update US prescribing information on fingolimod (Gilenya) to include
    updated patient selection parameters based on certain cardiovascular considerations to aid in the identification of
    candidates for Gilenya.</description>

    <dc:date>2012-04-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/172012/770531null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-EASD-issue-joint-position-statement-on-hypergl/ArticleStandard/Article/detail/770069?contextCategoryId=47453&amp;ref=25">

    <title>ADA, EASD issue joint position statement on hyperglycemia treatment for T2DM</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/ADA-EASD-issue-joint-position-statement-on-hypergl/ArticleStandard/Article/detail/770069?contextCategoryId=47453&amp;ref=25</link>

    <description>Guidelines for managing elevated blood glucose levels in people with type 2 diabetes mellitus,
    developed jointly by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes
    (EASD), are being published concurrently in the ADA?s journal, April 19 online edition of Diabetes Care and in
    EASD?s journal, Diabetologia.</description>

    <dc:date>2012-04-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/770069null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-approves-pregnancy-category-change-for-insulin/ArticleStandard/Article/detail/769828?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves pregnancy category change for insulin detemir injection</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-approves-pregnancy-category-change-for-insulin/ArticleStandard/Article/detail/769828?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved insulin detemir [rDNA origin] injection (Levemir, Novo Nordisk) pregnancy Category B
    classification, indicating that when used in pregnant women with diabetes, the injection did not increase the risk
    of harm to the unborn baby.</description>

    <dc:date>2012-04-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769828null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Fibromyalgia-patients-taking-pregabalin-see-/ArticleStandard/Article/detail/769829?contextCategoryId=47453&amp;ref=25">

    <title>Study: Fibromyalgia patients taking pregabalin see improvement in sleep, daily pain</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Fibromyalgia-patients-taking-pregabalin-see-/ArticleStandard/Article/detail/769829?contextCategoryId=47453&amp;ref=25</link>

    <description>Fibromyalgia patients taking pregabalin had significant improvements in sleep and decreased daily
    pain, according to a new study published in the April 2012 issue of Arthritis Care &amp;amp;amp;
    Research.</description>

    <dc:date>2012-04-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769829null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Periprocedural-dabigatran-use-is-associated-with-h/ArticleStandard/Article/detail/769827?contextCategoryId=47453&amp;ref=25">

    <title>Periprocedural dabigatran use is associated with higher major bleeding rate than warfarin, study
    finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Periprocedural-dabigatran-use-is-associated-with-h/ArticleStandard/Article/detail/769827?contextCategoryId=47453&amp;ref=25</link>

    <description>Patients using periprocedural dabigatran had a significantly higher major bleeding rate than those
    using warfarin, according to a study published online first February 1, 2012, in the Journal of the American
    College of Cardiology.</description>

    <dc:date>2012-04-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769827null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/CDC-calls-for-better-stewardship-to-combat-iC-diff/ArticleStandard/Article/detail/769643?contextCategoryId=47453&amp;ref=25">

    <title>CDC calls for better stewardship to combat C. difficile mortality</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/CDC-calls-for-better-stewardship-to-combat-iC-diff/ArticleStandard/Article/detail/769643?contextCategoryId=47453&amp;ref=25</link>

    <description>Clostridium difficile-associated diarrhea now accounts for about 14,000 deaths per year in the United
    States. CDC is calling on hospitals to exercise better antibiotic stewardship to help stem the tide.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769643/195x210_Pg-42_Ron-Polk_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Associations/New-AHA-guidelines-help-manage-hypertension-in-the/ArticleStandard/Article/detail/769654?contextCategoryId=47453&amp;ref=25">

    <title>New AHA guidelines help manage hypertension in the elderly</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Associations/New-AHA-guidelines-help-manage-hypertension-in-the/ArticleStandard/Article/detail/769654?contextCategoryId=47453&amp;ref=25</link>

    <description>The new guidelines are based on data from 2 trials that focused specifically on treating elderly
    patients for hypertension, which hadn't been done before.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769654null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-dabigatran-safety-concerns/ArticleStandard/Article/detail/769651?contextCategoryId=47453&amp;ref=25">

    <title>New dabigatran safety concerns</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-dabigatran-safety-concerns/ArticleStandard/Article/detail/769651?contextCategoryId=47453&amp;ref=25</link>

    <description>The safety of dabigatran is being called into question again. Concern has arisen about an increased
    risk of myocardial infarction in patients who are treated with the drug.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769651null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Helping-patients-with-diabetes-and-visual-or-manua/ArticleStandard/Article/detail/769639?contextCategoryId=47453&amp;ref=25">

    <title>Helping patients with diabetes and visual or manual impairment (part 1)</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Helping-patients-with-diabetes-and-visual-or-manua/ArticleStandard/Article/detail/769639?contextCategoryId=47453&amp;ref=25</link>

    <description>Learn about assistive devices and strategies to help improve care for these particular
    patients.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769639null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Kansas-launches-remote-supervision-for-hospital-ph/ArticleStandard/Article/detail/769641?contextCategoryId=47453&amp;ref=25">

    <title>Kansas launches remote supervision for hospital pharmacy techs</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Kansas-launches-remote-supervision-for-hospital-ph/ArticleStandard/Article/detail/769641?contextCategoryId=47453&amp;ref=25</link>

    <description>Chalk up a first for hospital pharmacists in Kansas. Video conferencing was used to supervise a
    pharmacy tech working in a hospital 200 miles across the state.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769641null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Better-clinical-decision-support-improves-CPOE-eff/ArticleStandard/Article/detail/769640?contextCategoryId=47453&amp;ref=25">

    <title>Better clinical decision support improves CPOE effectiveness</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Better-clinical-decision-support-improves-CPOE-eff/ArticleStandard/Article/detail/769640?contextCategoryId=47453&amp;ref=25</link>

    <description>An effective CPOE system needs clinical decision support to help prescribers, pharmacists, nurses, and
    others use the system effectively.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769640null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-treatments-available-for-actinic-keratosis-met/ArticleStandard/Article/detail/769638?contextCategoryId=47453&amp;ref=25">

    <title>New treatments available for actinic keratosis, methotrexate toxicity</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/New-treatments-available-for-actinic-keratosis-met/ArticleStandard/Article/detail/769638?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved ingenol mebutate gel and glucarpidase intravenous injection.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769638null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacist-led-interventions-reduced-prescribing-e/ArticleStandard/Article/detail/769652?contextCategoryId=47453&amp;ref=25">

    <title>Pharmacist-led interventions reduced prescribing errors, study finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacist-led-interventions-reduced-prescribing-e/ArticleStandard/Article/detail/769652?contextCategoryId=47453&amp;ref=25</link>

    <description>Prescribing errors in primary care offices were significantly reduced with pharmacist intervention,
    according to a recent study.</description>

    <dc:date>2012-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/162012/769652null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-shows-link-between-greater-cost-sharing-and-/ArticleStandard/Article/detail/768796?contextCategoryId=47453&amp;ref=25">

    <title>Study shows link between greater cost-sharing and higher hospitalization rates for asthmatic
    children</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-shows-link-between-greater-cost-sharing-and-/ArticleStandard/Article/detail/768796?contextCategoryId=47453&amp;ref=25</link>

    <description>Greater cost-sharing of asthma medications led to higher hospitalization rates in children 5 years or
    older, according to a new study published in the March 28 issue of JAMA.</description>

    <dc:date>2012-04-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768796null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Two-antidepressants-decrease-depression-in-Parkins/ArticleStandard/Article/detail/768795?contextCategoryId=47453&amp;ref=25">

    <title>Two antidepressants decrease depression in Parkinson's patients, study finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Two-antidepressants-decrease-depression-in-Parkins/ArticleStandard/Article/detail/768795?contextCategoryId=47453&amp;ref=25</link>

    <description>Certain antidepressants decrease depression in people with Parkinson?s disease without worsening their
    motor problems, according to a new study published in Neurology.</description>

    <dc:date>2012-04-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768795null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Fluoroquinolones-may-increase-risk-of-retinal-deta/ArticleStandard/Article/detail/768794?contextCategoryId=47453&amp;ref=25">

    <title>Fluoroquinolones may increase risk of retinal detachment</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Fluoroquinolones-may-increase-risk-of-retinal-deta/ArticleStandard/Article/detail/768794?contextCategoryId=47453&amp;ref=25</link>

    <description>Oral fluoroquinolones, one of the most commonly prescribed classes of antibiotics, may increase a
    person?s risk for developing a retinal detachment, according to a study published April 4 in JAMA.</description>

    <dc:date>2012-04-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768794null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-updates-drospirenone-containing-birth-control-/ArticleStandard/Article/detail/768692?contextCategoryId=47453&amp;ref=25">

    <title>FDA updates drospirenone-containing birth control pill labels to emphasize possible increased risk of blood
    clots in women</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-updates-drospirenone-containing-birth-control-/ArticleStandard/Article/detail/768692?contextCategoryId=47453&amp;ref=25</link>

    <description>Drospirenone-containing birth control pills may be associated with a higher risk for blood clots than
    other progestin-containing pills, according to recent FDA observational (epidemiologic) studies.</description>

    <dc:date>2012-04-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768692null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/CMS-announces-the-formation-of-27-ACOs-serving-375/ArticleStandard/Article/detail/768468?contextCategoryId=47453&amp;ref=25">

    <title>CMS announces the formation of 27 ACOs, serving 375,000 beneficiaries</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/CMS-announces-the-formation-of-27-ACOs-serving-375/ArticleStandard/Article/detail/768468?contextCategoryId=47453&amp;ref=25</link>

    <description>Under the new Medicare Shared Savings Program, 27 accountable care organizations (ACOs) have entered
    into agreements with the Centers for Medicare and Medicaid Services.</description>

    <dc:date>2012-04-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768468null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/FDA/Label-change-of-liraglutide-demonstrates-superiori/ArticleStandard/Article/detail/768397?contextCategoryId=47453&amp;ref=25">

    <title>Label change of liraglutide demonstrates superiority compared to sitagliptin</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/FDA/Label-change-of-liraglutide-demonstrates-superiori/ArticleStandard/Article/detail/768397?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved an update to the product label of liraglutide [rDNA] injection (Victoza, Novo Nordisk),
    which includes data demonstrating superior blood sugar control and weight reduction when compared with sitagliptin
    (Januvia, Merck), according to a press release from Novo Nordisk.</description>

    <dc:date>2012-04-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768397null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/FDA/Basal-insulin-approved-for-pregnant-women/ArticleStandard/Article/detail/768311?contextCategoryId=47453&amp;ref=25">

    <title>Basal insulin approved for pregnant women</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/FDA/Basal-insulin-approved-for-pregnant-women/ArticleStandard/Article/detail/768311?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved the first and only basal insulin analog (Levemir, Novo Nordisk) for use in pregnant
    women, the company announced last week.</description>

    <dc:date>2012-04-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/152012/768311null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Rivaroxaban-as-effective-as-standard-therapy-for-t/ArticleStandard/Article/detail/767790?contextCategoryId=47453&amp;ref=25">

    <title>Rivaroxaban as effective as standard therapy for treating PE with lower risk of bleeding</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Rivaroxaban-as-effective-as-standard-therapy-for-t/ArticleStandard/Article/detail/767790?contextCategoryId=47453&amp;ref=25</link>

    <description>Rivaroxaban, an oral blood thinner, is equally effective as standard therapy for the treatment of
    pulmonary embolism and may cause fewer bleeding complications, according to new data</description>

    <dc:date>2012-04-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142012/767790null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-guidelines-Dont-treat-most-sinus-infections-wi/ArticleStandard/Article/detail/767788?contextCategoryId=47453&amp;ref=25">

    <title>New guidelines: Don't treat most sinus infections with antibiotics</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-guidelines-Dont-treat-most-sinus-infections-wi/ArticleStandard/Article/detail/767788?contextCategoryId=47453&amp;ref=25</link>

    <description>The majority (90% to 98%) of sinus infections are caused by viruses and should not be treated with
    antibiotics, according to new guidelines from the Infectious Diseases Society of America.</description>

    <dc:date>2012-04-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142012/767788null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Blood-pressure-drug-might-curb-PTSD-related-nightm/ArticleStandard/Article/detail/767786?contextCategoryId=47453&amp;ref=25">

    <title>Blood-pressure drug might curb PTSD-related nightmares</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Blood-pressure-drug-might-curb-PTSD-related-nightm/ArticleStandard/Article/detail/767786?contextCategoryId=47453&amp;ref=25</link>

    <description>The blood-pressure medication prazosin was found to be an effective treatment to curb nightmares
    related to post traumatic stress disorder, according to a poster presentation, at the 20th European Congress of
    Psychiatry in Prague</description>

    <dc:date>2012-04-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142012/767786null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Rituximab-may-be-better-second-line-RA-therapy-whe/ArticleStandard/Article/detail/767787?contextCategoryId=47453&amp;ref=25">

    <title>Rituximab may be better second-line RA therapy when anti-TNF fails</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Rituximab-may-be-better-second-line-RA-therapy-whe/ArticleStandard/Article/detail/767787?contextCategoryId=47453&amp;ref=25</link>

    <description>Switching patients with rheumatoid arthritis to rituximab (Rituxan, Genentech) may be more effective
    than switching them to a second alternative anti-tumor necrosis factor (anti-TNF) after a first anti-TNF therapy
    has failed, according to a study published online in Arthritis Care &amp;amp;amp; Research.</description>

    <dc:date>2012-04-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142012/767787null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Risk-of-secondary-cases-of-iC-difficilei-in-househ/ArticleStandard/Article/detail/767789?contextCategoryId=47453&amp;ref=25">

    <title>Risk of secondary cases of C. difficile in households doesn't justify interventions</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Risk-of-secondary-cases-of-iC-difficilei-in-househ/ArticleStandard/Article/detail/767789?contextCategoryId=47453&amp;ref=25</link>

    <description>The risk of Clostridium difficile infection among households is too low to justify interventions,
    other than avoiding unnecessary antimicrobials, according to a new study, published in April?s Journal of
    Infection.</description>

    <dc:date>2012-04-05T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/142012/767789null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Antioxidants-may-not-benefit-patients-with-Alzheim/ArticleStandard/Article/detail/766472?contextCategoryId=47453&amp;ref=25">

    <title>Antioxidants may not benefit patients with Alzheimer's disease</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Antioxidants-may-not-benefit-patients-with-Alzheim/ArticleStandard/Article/detail/766472?contextCategoryId=47453&amp;ref=25</link>

    <description>Daily supplementation with antioxidants, vitamins E and C, and alpha acid, did not improve memory
    function in patients with Alzheimer?s disease, according to a new study.</description>

    <dc:date>2012-03-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/132012/766472null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/3-studies-find-aspirin-reduces-risk-of-cancer-deat/ArticleStandard/Article/detail/766470?contextCategoryId=47453&amp;ref=25">

    <title>3 studies find aspirin reduces risk of cancer deaths, metastasis</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/3-studies-find-aspirin-reduces-risk-of-cancer-deat/ArticleStandard/Article/detail/766470?contextCategoryId=47453&amp;ref=25</link>

    <description>Aspirin can reduce the risk for cancer-related mortality and can reduce or prevent the risk for
    distant metastasis, according to 3 new studies published online by The Lancet and The Lancet
    Oncology.</description>

    <dc:date>2012-03-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/132012/766470null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-adds-new-label-warnings-for-the-antidepressant/ArticleStandard/Article/detail/766419?contextCategoryId=47453&amp;ref=25">

    <title>FDA adds new label warnings for the antidepressant citalopram</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-adds-new-label-warnings-for-the-antidepressant/ArticleStandard/Article/detail/766419?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA added new label warnings for the antidepressant citalopram (Celexa, Forest Laboratories),
    discouraging patients with certain conditions from using the drug and lowering the dosage recommendations to 20 mg
    daily for patients aged 60 and older. The warning is also applicable to generic versions of Celexa.</description>

    <dc:date>2012-03-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/132012/766419null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-once-monthly-treatment-for-anemic-adu/ArticleStandard/Article/detail/766235?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves once-monthly treatment for anemic adults on dialysis</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-once-monthly-treatment-for-anemic-adu/ArticleStandard/Article/detail/766235?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved peginesatide (Omontys, Affymax) to treat anemia in adult dialysis patients who have
    chronic kidney disease (CKD).</description>

    <dc:date>2012-03-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/132012/766235null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Alzheimers-drugs-donepezil-memantine-show-some-ben/ArticleStandard/Article/detail/765556?contextCategoryId=47453&amp;ref=25">

    <title>Alzheimer's drugs donepezil, memantine show some benefits in study</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Alzheimers-drugs-donepezil-memantine-show-some-ben/ArticleStandard/Article/detail/765556?contextCategoryId=47453&amp;ref=25</link>

    <description>A new study of patients with moderate to severe Alzheimer's disease found that extended treatment with
    donepezil could improve cognition and function for even severe patients; however, experts caution that the benefits
    of the drug were modest</description>

    <dc:date>2012-03-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/122012/765556null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-highlights-need-to-treat-nursing-home-patien/ArticleStandard/Article/detail/765559?contextCategoryId=47453&amp;ref=25">

    <title>Study highlights need to treat nursing-home patients for vitamin D deficiency</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-highlights-need-to-treat-nursing-home-patien/ArticleStandard/Article/detail/765559?contextCategoryId=47453&amp;ref=25</link>

    <description>The majority of older women in nursing homes are likely to be deficient in vitamin D during winter
    months, and those with the lowest levels are at a significantly increased risk of death, according to a study
    published online February 8, in the Journal of Clinical Endocrinology</description>

    <dc:date>2012-03-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/122012/765559null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Heroin-may-be-more-effective-than-methadone-for-re/ArticleStandard/Article/detail/765557?contextCategoryId=47453&amp;ref=25">

    <title>Heroin may be more effective than methadone for relapsing addicts</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Heroin-may-be-more-effective-than-methadone-for-re/ArticleStandard/Article/detail/765557?contextCategoryId=47453&amp;ref=25</link>

    <description>Diacetylmorphine, or heroin, may be a more effective, cheaper treatment than methadone for people with
    relapsing chronic opioid dependence, according to a study published in the Canadian Medical Association
    Journal.</description>

    <dc:date>2012-03-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/122012/765557null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Ingenol-mebutate-gel-is-effective-treatment-for-ac/ArticleStandard/Article/detail/765558?contextCategoryId=47453&amp;ref=25">

    <title>Ingenol mebutate gel is effective treatment for actinic keratosis, study shows</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Ingenol-mebutate-gel-is-effective-treatment-for-ac/ArticleStandard/Article/detail/765558?contextCategoryId=47453&amp;ref=25</link>

    <description>Ingenol mebutate topical gel (0.015% for face and scalp and 0.05% for trunk and extremities) was
    effective for treating actinic keratoses, a common precursor to sun-related, squamos-cell carcinoma, according to a
    new study.</description>

    <dc:date>2012-03-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/122012/765558null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-drug-for-myelofibrosis/ArticleStandard/Article/detail/764136?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves drug for myelofibrosis</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-drug-for-myelofibrosis/ArticleStandard/Article/detail/764136?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved ruxolitinib (Jakafi), a twice-daily tablet, indicated for the treatment of myelofibrosis,
    a rare bone marrow disease that affects less than 200,000 people in the United States.</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/764136null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Not-all-omega-3-fish-oils-are-equal/ArticleStandard/Article/detail/764145?contextCategoryId=47453&amp;ref=25">

    <title>Not all omega-3 fish oils are equal</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Not-all-omega-3-fish-oils-are-equal/ArticleStandard/Article/detail/764145?contextCategoryId=47453&amp;ref=25</link>

    <description>Experts caution that many unregulated over-the-counter fish oil products have little benefit, with
    some having no benefit at all.</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/764145null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-oral-contraceptive-to-treat-hea/ArticleStandard/Article/detail/764751?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves first oral contraceptive to treat heavy menstrual bleeding</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-oral-contraceptive-to-treat-hea/ArticleStandard/Article/detail/764751?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved a new indication for estradiol valerate and estradiol valerate/dienogest (Natazia,
    Bayer HealthCare Pharmaceuticals) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by
    any diagnosed conditions of the uterus.</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112012/764751null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Anticoagulation-may-be-safe-for-many-outpatient-pr/ArticleStandard/Article/detail/764155?contextCategoryId=47453&amp;ref=25">

    <title>Anticoagulation may be safe for many outpatient procedures</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Anticoagulation-may-be-safe-for-many-outpatient-pr/ArticleStandard/Article/detail/764155?contextCategoryId=47453&amp;ref=25</link>

    <description>It can be helpful to know the guidelines concerning anticoagulation and common outpatient
    procedures.</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/764155null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Adding-prednisone-to-treatment-improves-rheu/ArticleStandard/Article/detail/764662?contextCategoryId=47453&amp;ref=25">

    <title>Study: Adding prednisone to treatment improves rheumatoid arthritis symptoms</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Adding-prednisone-to-treatment-improves-rheu/ArticleStandard/Article/detail/764662?contextCategoryId=47453&amp;ref=25</link>

    <description>Patients' rheumatoid arthritis symptoms improved after adding prednisone at the start of a
    methotrexate-based treatment strategy, according to research published in the March 6 issue of the Annals of
    Internal Medicine.</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112012/764662null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Aspirin-may-reduce-incidence-of-strokes-in-postmen/ArticleStandard/Article/detail/764663?contextCategoryId=47453&amp;ref=25">

    <title>Aspirin may reduce incidence of strokes in postmenopausal women with high trans-fat intake</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Aspirin-may-reduce-incidence-of-strokes-in-postmen/ArticleStandard/Article/detail/764663?contextCategoryId=47453&amp;ref=25</link>

    <description>Postmenopausal women with higher intake of trans fat were associated with a higher incidence of
    ischemic stroke but aspirin may reduce the adverse effects of trans fat, according to a new study</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112012/764663null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacogenomics-and-practical-applications/ArticleStandard/Article/detail/764147?contextCategoryId=47453&amp;ref=25">

    <title>Pharmacogenomics and practical applications</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/Pharmacogenomics-and-practical-applications/ArticleStandard/Article/detail/764147?contextCategoryId=47453&amp;ref=25</link>

    <description>The next decade will see a significant increase in the rate of practical applications for
    pharmacogenomics becoming available, and pharmacists will play a critical role in helping them benefit the
    patient.</description>

    <dc:date>2012-03-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/764147null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-effervescent-osteoporosis-treat/ArticleStandard/Article/detail/764690?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves first effervescent osteoporosis treatment in a buffered solution</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-effervescent-osteoporosis-treat/ArticleStandard/Article/detail/764690?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved alendronate sodium (Binosto, EffRx Pharmaceuticals) effervescent tablets, the first
    effervescent osteoporosis treatment in a buffered solution.</description>

    <dc:date>2012-03-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112012/764690null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-generic-Lexapro-to-treat-depres/ArticleStandard/Article/detail/764666?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves first generic Lexapro to treat depression, anxiety disorder</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-first-generic-Lexapro-to-treat-depres/ArticleStandard/Article/detail/764666?contextCategoryId=47453&amp;ref=25</link>

    <description>Teva/IVAX Pharmaceuticals gained FDA approval for the first generic version of Lexapro (Forest) to
    treat both depression and generalized anxiety disorder in adults. The company will have 180 days to exclusively
    sell the product.</description>

    <dc:date>2012-03-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/112012/764666null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Bevacizumab-an-effective-treat-and-extend-regimen-/ArticleStandard/Article/detail/763746?contextCategoryId=47453&amp;ref=25">

    <title>Bevacizumab an effective treat-and-extend regimen for AMD</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Bevacizumab-an-effective-treat-and-extend-regimen-/ArticleStandard/Article/detail/763746?contextCategoryId=47453&amp;ref=25</link>

    <description>A treat-and-extend regimen of intravitreal bevacizumab (Avastin, Genentech) produced ?significant
    visual improvements? for eyes with neovascular age-related macular degeneration, according to an article published
    in the March issue of the American Journal of Ophthalmology.</description>

    <dc:date>2012-03-08T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/763746null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-panel-recommends-approval-of-aclidinium-bromid/ArticleStandard/Article/detail/763744?contextCategoryId=47453&amp;ref=25">

    <title>FDA panel recommends approval of aclidinium bromide for COPD</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-panel-recommends-approval-of-aclidinium-bromid/ArticleStandard/Article/detail/763744?contextCategoryId=47453&amp;ref=25</link>

    <description>An FDA advisory panel voted 12-2 to recommend approval of aclidinium bromide (Forest Laboratories and
    Almirall SA) 400 &amp;amp;micro;g twice daily for the long-term maintenance treatment of bronchospasm associated
    with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.</description>

    <dc:date>2012-03-08T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/763744null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/AAP-now-recommends-HPV-vaccine-for-boys/ArticleStandard/Article/detail/763742?contextCategoryId=47453&amp;ref=25">

    <title>AAP now recommends HPV vaccine for boys</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/AAP-now-recommends-HPV-vaccine-for-boys/ArticleStandard/Article/detail/763742?contextCategoryId=47453&amp;ref=25</link>

    <description>New guidelines for the use of the quadrivalent human papillomavirus vaccine, published by the American
    Academy of Pediatrics, recommend for the first time vaccinating adolescent boys as well as girls.</description>

    <dc:date>2012-03-08T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/102012/763742null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-warning-Co-administration-of-statins-and-prote/ArticleStandard/Article/detail/762965?contextCategoryId=47453&amp;ref=25">

    <title>FDA warning: Co-administration of statins and protease inhibitors increases risk of muscle injury</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-warning-Co-administration-of-statins-and-prote/ArticleStandard/Article/detail/762965?contextCategoryId=47453&amp;ref=25</link>

    <description>Thursday, FDA updated its recommendations concerning drug-drug interactions between protease
    inhibitors and statins, warning of an increased risk of muscle injury (myopathy). The most serious form of
    myopathy, rhabdomyolysis, can damage kidneys and lead to kidney failure, which can be fatal.</description>

    <dc:date>2012-03-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092012/762965null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/The+Latest/FDA-approves-first-4-strain-flu-vaccine/ArticleStandard/Article/detail/762697?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves first 4-strain flu vaccine</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/The+Latest/FDA-approves-first-4-strain-flu-vaccine/ArticleStandard/Article/detail/762697?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved the first intranasal quadrivalent influenza vaccine (FluMist Quadrivalent, MedImmune)
    for prevention of influenza.</description>

    <dc:date>2012-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092012/762697null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-approves-2-pancreatic-enzyme-products-to-aid-f/ArticleStandard/Article/detail/762777?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves 2 pancreatic enzyme products to aid food digestion</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Clinical+News/FDA-approves-2-pancreatic-enzyme-products-to-aid-f/ArticleStandard/Article/detail/762777?contextCategoryId=47453&amp;ref=25</link>

    <description>Two new pancreatic enzyme products used to help aid food digestion, both of which are forms of
    pancrelipase (Ultresa and Viokace, Aptalis), have been approved by FDA.</description>

    <dc:date>2012-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092012/762777null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-IM-injections-more-effective-than-IVs-for-st/ArticleStandard/Article/detail/762519?contextCategoryId=47453&amp;ref=25">

    <title>Study: IM injections more effective than IVs for stopping seizures</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-IM-injections-more-effective-than-IVs-for-st/ArticleStandard/Article/detail/762519?contextCategoryId=47453&amp;ref=25</link>

    <description>Intramuscular injections with midazolam may be more effective than the intravenous administrations
    used by paramedics to stop prolonged seizures, according to a study published February 16 in the New England
    Journal of Medicine.</description>

    <dc:date>2012-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092012/762519null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Acellular-pertussis-vaccinations-increase-risk-of-/ArticleStandard/Article/detail/762517?contextCategoryId=47453&amp;ref=25">

    <title>Acellular pertussis vaccinations increase risk of febrile seizures, study finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Acellular-pertussis-vaccinations-increase-risk-of-/ArticleStandard/Article/detail/762517?contextCategoryId=47453&amp;ref=25</link>

    <description>The risk of febrile seizure was elevated the first two of three times that a combination shot
    containing acellular pertussis vaccine was administered to infants, although the absolute risk remained low,
    according to a Danish study that appeared in the February 22/29 issue of JAMA.</description>

    <dc:date>2012-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092012/762517null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/The+Latest/FDA-warns-of-potential-diabetes-risk-cognitive-adv/ArticleStandard/Article/detail/762396?contextCategoryId=47453&amp;ref=25">

    <title>FDA warns of potential diabetes risk, cognitive adverse events with statins</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/The+Latest/FDA-warns-of-potential-diabetes-risk-cognitive-adv/ArticleStandard/Article/detail/762396?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved label changes for all statins to warn patients of the potential risk of increased
    blood-glucose levels and diabetes as well as memory loss when taking these medications. However, FDA also removed
    the need for routine periodic monitoring of liver enzymes in patients taking statins, according to an FDA drug
    safety communication issued this week.</description>

    <dc:date>2012-02-29T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/092012/762396null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/ACIP-expands-recommendations-for-whooping-cough-va/ArticleStandard/Article/detail/761590?contextCategoryId=47453&amp;ref=25">

    <title>ACIP expands recommendations for whooping cough vaccine to 65 and older</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/ACIP-expands-recommendations-for-whooping-cough-va/ArticleStandard/Article/detail/761590?contextCategoryId=47453&amp;ref=25</link>

    <description>The Advisory Committee on Immunization Practices (ACIP) wants all U.S. adults to get vaccinated
    against whooping cough, according to the Associated Press. The panel voted to expand its recommendation to include
    all those aged 65 years and older who haven?t gotten a whooping cough shot as an adult.</description>

    <dc:date>2012-02-23T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761590null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Most-cases-of-CDI-arent-being-spread-by-pati/ArticleStandard/Article/detail/761454?contextCategoryId=47453&amp;ref=25">

    <title>Study: Most cases of CDI aren't being spread by patients in same ward</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Most-cases-of-CDI-arent-being-spread-by-pati/ArticleStandard/Article/detail/761454?contextCategoryId=47453&amp;ref=25</link>

    <description>A recent study challenges the conventional assumption about how Clostridium difficile infection
    spreads in hospitals, finding that almost three-quarters of the new cases aren?t transmitted by patients in the
    same ward.</description>

    <dc:date>2012-02-23T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761454null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Antibiotic-amoxicillin-no-help-in-treating-acute-r/ArticleStandard/Article/detail/761452?contextCategoryId=47453&amp;ref=25">

    <title>Antibiotic amoxicillin no help in treating acute rhinosinusitis</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Antibiotic-amoxicillin-no-help-in-treating-acute-r/ArticleStandard/Article/detail/761452?contextCategoryId=47453&amp;ref=25</link>

    <description>No significant difference was found in treating patients experiencing clinically diagnosed
    uncomplicated acute rhinosinusitis with antibiotic amoxicillin compared with patients who received placebo,
    according to a study in the February 15 issue of JAMA.</description>

    <dc:date>2012-02-23T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761452null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Zinc-plus-antibiotics-saves-lives-of-children-with/ArticleStandard/Article/detail/761455?contextCategoryId=47453&amp;ref=25">

    <title>Zinc plus antibiotics saves lives of children with pneumonia, study finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Zinc-plus-antibiotics-saves-lives-of-children-with/ArticleStandard/Article/detail/761455?contextCategoryId=47453&amp;ref=25</link>

    <description>Zinc used in addition to antibiotics significantly reduced mortality in children ages 6 months to 59
    months with severe pneumonia when compared with antibiotics alone, according to the findings of a recent study done
    in Uganda.</description>

    <dc:date>2012-02-23T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761455null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/No-benefit-of-B-vitamins-or-omega-3-on-cancer-outc/ArticleStandard/Article/detail/761453?contextCategoryId=47453&amp;ref=25">

    <title>No benefit of B vitamins or omega-3 on cancer outcomes, study finds</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/No-benefit-of-B-vitamins-or-omega-3-on-cancer-outc/ArticleStandard/Article/detail/761453?contextCategoryId=47453&amp;ref=25</link>

    <description>There are no beneficial effects of supplementation with relatively low doses of B vitamins and/or
    omega-3 fatty acids on cancer outcomes in individuals with prior cardiovascular disease, according to a study
    published online February 13 in the Archives of Internal Medicine.</description>

    <dc:date>2012-02-23T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761453null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/RxIMPACT-Day-an-opportunity-for-pharmacists-to-spe/ArticleStandard/Article/detail/759140?contextCategoryId=47453&amp;ref=25">

    <title>RxIMPACT Day an opportunity for pharmacists to speak out</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/RxIMPACT-Day-an-opportunity-for-pharmacists-to-spe/ArticleStandard/Article/detail/759140?contextCategoryId=47453&amp;ref=25</link>

    <description>Community pharmacists are encouraged to express their views to lawmakers at the National Association
    of Chain Drug Stores&amp;amp;rsquo; 4th annual RxIMPACT Day in Washington, D.C., in March.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759140null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/California-regulates-OTC-cough-and-cold-products-t/ArticleStandard/Article/detail/759143?contextCategoryId=47453&amp;ref=25">

    <title>California regulates OTC cough and cold products to cut abuse by youths</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/California-regulates-OTC-cough-and-cold-products-t/ArticleStandard/Article/detail/759143?contextCategoryId=47453&amp;ref=25</link>

    <description>California has become the first state to regulate dextromethorphan (DXM), an antitussive in Benylin,
    Pertussin, Robitussin, and dozens of other over-the-counter cough and cold products. A state law that went into
    effect Jan. 1 prohibits sales of products containing DXM to anyone under the age of 18 without a
    prescription.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759143null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-acts-to-bolster-supply-of-critically-needed-ca/ArticleStandard/Article/detail/761240?contextCategoryId=47453&amp;ref=25">

    <title>FDA acts to bolster supply of critically needed cancer drugs</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-acts-to-bolster-supply-of-critically-needed-ca/ArticleStandard/Article/detail/761240?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA announced a series of steps to increase the supply of critically needed cancer drugs, including
    temporarily allowing 2 drugs to be imported. The moves are building on President Barack Obama?s executive order to
    help prevent future drug shortages, FDA said.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761240null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/NCPA-NACDS-protest-TRICARE-limitations-in-Obama-bu/ArticleStandard/Article/detail/759139?contextCategoryId=47453&amp;ref=25">

    <title>NCPA, NACDS protest TRICARE limitations in Obama budget</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/NCPA-NACDS-protest-TRICARE-limitations-in-Obama-bu/ArticleStandard/Article/detail/759139?contextCategoryId=47453&amp;ref=25</link>

    <description>Retail pharmacy groups are urging Congress to reject budget proposals that would limit pharmacy choice
    for TRICARE beneficiaries.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759139null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Whatrsquos-new-on-the-shelves/ArticleStandard/Article/detail/759141?contextCategoryId=47453&amp;ref=25">

    <title>What&amp;amp;rsquo;s new on the shelves?</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Whatrsquos-new-on-the-shelves/ArticleStandard/Article/detail/759141?contextCategoryId=47453&amp;ref=25</link>

    <description>What&amp;amp;rsquo;s different on your local drug-store counters this month? You can try 2 new flavors
    of organic tooth powders. There&amp;amp;rsquo;s a prenatal vitamin designed to optimize DHA levels in
    mother&amp;amp;rsquo;s milk. You&amp;amp;rsquo;ll find a cocktail of natural oils for spot relief of pain or dry
    skin. A new hand and body lotion promotes healthy blood flow. A multivitamin has been created to improve your
    vision. Five organic lip and body balms now come in easy-to-carry containers. And there are even more new
    over-the-counter items featured in the print edition of Drug Topics.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759141null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/AACP-joins-with-healthcare-professions-to-improve-/ArticleStandard/Article/detail/759142?contextCategoryId=47453&amp;ref=25">

    <title>AACP joins other healthcare professions to improve education collaboration</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/AACP-joins-with-healthcare-professions-to-improve-/ArticleStandard/Article/detail/759142?contextCategoryId=47453&amp;ref=25</link>

    <description>The American Association of Colleges of Pharmacy (AACP) has formally joined 5 other national health
    professions to create the Interprofessional Education Collaborative (IPEC), a new national organization that will
    focus on improved integration and coordination of the education of pharmacists and other healthcare workers to
    provide more collaborative care.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759142null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Georgia-voters-strongly-oppose-mandatory-mail-orde/ArticleStandard/Article/detail/759138?contextCategoryId=47453&amp;ref=25">

    <title>Georgia voters strongly oppose mandatory mail-order plans</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Georgia-voters-strongly-oppose-mandatory-mail-orde/ArticleStandard/Article/detail/759138?contextCategoryId=47453&amp;ref=25</link>

    <description>A whopping 82% of 600 Georgia voters surveyed said they oppose mandatory mail-order
    plans.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759138null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/First-medication-approved-by-FDA-for-patients-with/ArticleStandard/Article/detail/761113?contextCategoryId=47453&amp;ref=25">

    <title>First medication approved by FDA for patients with endogenous Cushing's syndrome</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/First-medication-approved-by-FDA-for-patients-with/ArticleStandard/Article/detail/761113?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved the first medication therapy, mifepristone (Korlym, Corcept Therapeutics), for
    endrogenous Cushing?s syndrome, a condition that, left untreated, has a mortality rate of 50 percent after 5
    years.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/082012/761113null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/DEA-holding-Pharmacy-Diversion-Awareness-Conferenc/ArticleStandard/Article/detail/759144?contextCategoryId=47453&amp;ref=25">

    <title>DEA holding Pharmacy Diversion Awareness Conference in Florida</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/DEA-holding-Pharmacy-Diversion-Awareness-Conferenc/ArticleStandard/Article/detail/759144?contextCategoryId=47453&amp;ref=25</link>

    <description>The Drug Enforcement Administration will hold 2 one-day regional conferences in West Palm Beach, Fla.,
    next month in an effort to assist pharmacy personnel in identifying and responding to potential diversion
    activity.</description>

    <dc:date>2012-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759144null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-finds-association-between-open-angle-glaucom/ArticleStandard/Article/detail/759019?contextCategoryId=47453&amp;ref=25">

    <title>Study finds association between open-angle glaucoma and ED</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-finds-association-between-open-angle-glaucom/ArticleStandard/Article/detail/759019?contextCategoryId=47453&amp;ref=25</link>

    <description>Men with erectile dysfunction (ED) also were more likely to have had open-angle glaucoma than those
    without ED, according to a study published in the February 12 online issue of Opthalmology.</description>

    <dc:date>2012-02-16T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759019null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Poorly-controlled-diabetes-may-lead-to-hearing-los/ArticleStandard/Article/detail/759017?contextCategoryId=47453&amp;ref=25">

    <title>Poorly controlled diabetes may lead to hearing loss in women</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Poorly-controlled-diabetes-may-lead-to-hearing-los/ArticleStandard/Article/detail/759017?contextCategoryId=47453&amp;ref=25</link>

    <description>Uncontrolled diabetes may result in hearing loss in women much like it affects vision or kidney
    function, according to the results of a new study.</description>

    <dc:date>2012-02-16T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/759017null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-therapies-for-AMD-insomnia/ArticleStandard/Article/detail/758547?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves therapies for AMD, insomnia</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/FDA-approves-therapies-for-AMD-insomnia/ArticleStandard/Article/detail/758547?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved an intravitreal injection to treat patients with wet AMD and zolpidem to treat
    insomnia.</description>

    <dc:date>2012-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/062012/758547null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/More-stroke-patients-going-home-on-anticoagulants/ArticleStandard/Article/detail/758550?contextCategoryId=47453&amp;ref=25">

    <title>More stroke patients going home on anticoagulants</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Modern+Medicine+Now/More-stroke-patients-going-home-on-anticoagulants/ArticleStandard/Article/detail/758550?contextCategoryId=47453&amp;ref=25</link>

    <description>A recent study indicates that 95% of stroke patients with atrial fibrillation received prescriptions
    for anticoagulants in 2010 if they were treated at hospitals participating in the Get With The
    Guidelines&amp;amp;ndash;Stroke program.</description>

    <dc:date>2012-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/062012/758550null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-warning-Counterfeit-version-of-cancer-drug-Ava/ArticleStandard/Article/detail/758923?contextCategoryId=47453&amp;ref=25">

    <title>FDA warning: Counterfeit version of cancer drug Avastin circulating</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-warning-Counterfeit-version-of-cancer-drug-Ava/ArticleStandard/Article/detail/758923?contextCategoryId=47453&amp;ref=25</link>

    <description>Some cancer patients may not get proper treatment because a counterfeit version of the drug sold as
    Avastin 400mg/16mi has been purchased by as many as 19 medical practices in the United States, FDA warned
    Wednesday.</description>

    <dc:date>2012-02-15T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/758923null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-preservative-free-solution-for-glauco/ArticleStandard/Article/detail/758724?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves preservative-free solution for glaucoma, ocular hypertension</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-preservative-free-solution-for-glauco/ArticleStandard/Article/detail/758724?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has approved tafluprost ophthalmic solution (Zioptan, Merck) 0.0015%, the first preservative-free
    prostaglandin analog ophthalmic solution for reducing elevated intraocular pressure in patients with open-angle
    glaucoma or ocular hypertension.</description>

    <dc:date>2012-02-14T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/072012/758724null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-grants-priority-review-to-GI-agent-for-control/ArticleStandard/Article/detail/758084?contextCategoryId=47453&amp;ref=25">

    <title>FDA grants priority review to GI agent for controlling diarrhea in HIV/AIDS patients</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-grants-priority-review-to-GI-agent-for-control/ArticleStandard/Article/detail/758084?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA has granted priority review to crofelemer 125-mg tablets (Salix Pharmaceuticals) for the control
    and symptomatic relief of diarrhea in patients with HIV/AIDS on anti-retroviral therapy (ART).</description>

    <dc:date>2012-02-07T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/062012/758084null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-extended-release-tablets-for-type-2-d/ArticleStandard/Article/detail/757733?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves extended-release tablets for type 2 diabetes</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-extended-release-tablets-for-type-2-d/ArticleStandard/Article/detail/757733?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck)
    tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia
    (sitagliptin), with extended-release metformin.</description>

    <dc:date>2012-02-03T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/052012/757733null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-ivacaftor-to-treat-rare-form-of-cysti/ArticleStandard/Article/detail/757493?contextCategoryId=47453&amp;ref=25">

    <title>FDA approves ivacaftor to treat rare form of cystic fibrosis</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Chains+%26+Business/FDA-approves-ivacaftor-to-treat-rare-form-of-cysti/ArticleStandard/Article/detail/757493?contextCategoryId=47453&amp;ref=25</link>

    <description>FDA approved ivacaftor (Kalydeco, Vertex Pharmaceuticals) for the treatment of a rare form of cystic
    fibrosis in patients aged 6 years and older who have the specific G551D mutation in the Cystic Fibrosis
    Transmembrane Regulator gene.</description>

    <dc:date>2012-02-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/052012/757493null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Review-raises-questions-about-why-government-stock/ArticleStandard/Article/detail/757338?contextCategoryId=47453&amp;ref=25">

    <title>Review raises questions about why government stockpiling zanamivir, oseltamivir</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Review-raises-questions-about-why-government-stock/ArticleStandard/Article/detail/757338?contextCategoryId=47453&amp;ref=25</link>

    <description>Zanamivir and oseltamivir (Tamiflu, Roche) can help prevent and treat the symptoms of influenza, but
    there is not enough information to evaluate the drugs&amp;amp;rsquo; safety and efficacy for preventing the spread
    of flu or pneumonia, according to a new review published online January 18.</description>

    <dc:date>2012-01-31T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/052012/757338null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Blood-clots-likely-for-as-many-as-1-in-100-f/ArticleStandard/Article/detail/757108?contextCategoryId=47453&amp;ref=25">

    <title>Study: Blood clots likely for as many as 1 in 100 following joint replacements</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Blood-clots-likely-for-as-many-as-1-in-100-f/ArticleStandard/Article/detail/757108?contextCategoryId=47453&amp;ref=25</link>

    <description>Approximately 1 in 100 patients undergoing total or partial knee replacement surgery and 1 in 200
    patients undergoing total or partial hip replacement surgery will experience a venous thromboembolism event,
    including deep vein thrombosis and pulmonary embolism, before being discharged from the hospital, according to a
    study reported January 18 in the Journal of the American Medical Association.</description>

    <dc:date>2012-01-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/757108null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/FDA/Ranbaxy-accepts-consent-decree-permanent-injunctio/ArticleStandard/Article/detail/757134?contextCategoryId=47453&amp;ref=25">

    <title>Ranbaxy accepts consent decree, permanent injunction</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/FDA/Ranbaxy-accepts-consent-decree-permanent-injunctio/ArticleStandard/Article/detail/757134?contextCategoryId=47453&amp;ref=25</link>

    <description>Indian drug giant Ranbaxy has accepted a consent decree filed by the U.S. Department of Justice on
    behalf of FDA. The decree, which must still be accepted by the U.S. District Court for the District of Maryland,
    requires Ranbaxy to fix long-standing manufacturing problems at plants in India as well as a plant in the United
    States.</description>

    <dc:date>2012-01-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/757134null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Anti-infective-drug-shortages-affect-clinical-care/ArticleStandard/Article/detail/757111?contextCategoryId=47453&amp;ref=25">

    <title>Anti-infective drug shortages affect clinical care, outcomes</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Anti-infective-drug-shortages-affect-clinical-care/ArticleStandard/Article/detail/757111?contextCategoryId=47453&amp;ref=25</link>

    <description>Welcome to the latest public health emergency: Shortages of anti-infective agents. These shortages can
    adversely affect clinical care and patient outcomes, according to a new study.</description>

    <dc:date>2012-01-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/757111null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Use-of-aspirin-questioned-as-primary-prevention-fo/ArticleStandard/Article/detail/757112?contextCategoryId=47453&amp;ref=25">

    <title>Use of aspirin questioned as primary prevention for CVD</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Use-of-aspirin-questioned-as-primary-prevention-fo/ArticleStandard/Article/detail/757112?contextCategoryId=47453&amp;ref=25</link>

    <description>Aspirin prophylaxis in people without prior cardiovascular disease does not appear to reduce
    cardiovascular death or cancer mortality, however it was associated with reductions in nonfatal myocardial
    infarction, according to the results of a meta-analysis published online January 9 in the Archives of Internal
    Medicine.</description>

    <dc:date>2012-01-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/757112null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-guidelines-recommend-blood-glucose-testing-for/ArticleStandard/Article/detail/757109?contextCategoryId=47453&amp;ref=25">

    <title>New guidelines recommend blood-glucose testing for all hospitalized patients</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-guidelines-recommend-blood-glucose-testing-for/ArticleStandard/Article/detail/757109?contextCategoryId=47453&amp;ref=25</link>

    <description>The Endocrine Society recently released new clinical-practice guidelines recommending that all
    patients have their blood-glucose levels tested upon admission to the hospital, even if they haven&amp;amp;rsquo;t
    had a prior diagnosis of diabetes.</description>

    <dc:date>2012-01-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/757109null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Anti-infective-drug-shortages-affect-clinica/ArticleStandard/Article/detail/756882?contextCategoryId=47453&amp;ref=25">

    <title>Study: Anti-infective drug shortages affect clinical care, outcomes</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Study-Anti-infective-drug-shortages-affect-clinica/ArticleStandard/Article/detail/756882?contextCategoryId=47453&amp;ref=25</link>

    <description>Welcome to the latest public health emergency: Shortages of anti-infective agents. These shortages can
    adversely affect clinical care and patient outcomes according to a new study.</description>

    <dc:date>2012-01-24T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/756882null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Remington-Honor-Medal-to-go-to-director-of-St-Jude/ArticleStandard/Article/detail/756888?contextCategoryId=47453&amp;ref=25">

    <title>Remington Honor Medal to go to director of St. Jude Children's Research Hospital</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Remington-Honor-Medal-to-go-to-director-of-St-Jude/ArticleStandard/Article/detail/756888?contextCategoryId=47453&amp;ref=25</link>

    <description>William Edward Evans, PharmD, director and CEO at St Jude Children&amp;amp;rsquo;s Research Hospital,
    has been selected to receive pharmacy&amp;amp;rsquo;s highest award, the Remington Honor Medal, the American
    Pharmacists Association announced.</description>

    <dc:date>2012-01-24T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/042012/756888null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/ACP-Foundation-hopes-tools-can-help-prevent-stroke/ArticleStandard/Article/detail/756628?contextCategoryId=47453&amp;ref=25">

    <title>ACP Foundation hopes tools can help prevent strokes in patients with atrial fibrillation</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/ACP-Foundation-hopes-tools-can-help-prevent-stroke/ArticleStandard/Article/detail/756628?contextCategoryId=47453&amp;ref=25</link>

    <description>The ACP Foundation recently published a 31-page primer, Initiative on Atrial Fibrillation and Stroke
    Prevention, in the hopes of improving the care of patients with atrial fibrillation within health
    systems.</description>

    <dc:date>2012-01-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/032012/756628null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/Varicella-vaccination-program-cuts-infection-rate-/ArticleStandard/Article/detail/756629?contextCategoryId=47453&amp;ref=25">

    <title>Varicella vaccination program cuts infection rate in infants</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/Varicella-vaccination-program-cuts-infection-rate-/ArticleStandard/Article/detail/756629?contextCategoryId=47453&amp;ref=25</link>

    <description>The U.S. varicella vaccination program has substantial indirect benefits for infants, who are not
    eligible to receive the vaccine, a recent report from the Centers for Disease Control and Prevention
    shows.</description>

    <dc:date>2012-01-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/032012/756629null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-data-ADT-does-not-increase-cardiovascular-deat/ArticleStandard/Article/detail/756630?contextCategoryId=47453&amp;ref=25">

    <title>New data: ADT does not increase cardiovascular death risk</title>

    <link>
    http://drugtopics.modernmedicine.com/drugtopics/Top+News/New-data-ADT-does-not-increase-cardiovascular-deat/ArticleStandard/Article/detail/756630?contextCategoryId=47453&amp;ref=25</link>

    <description>Contrary to the conclusions of recent research, androgen deprivation therapy does not appear to raise
    the risk of fatal heart attacks in men being treated for prostate cancer, results from a multicenter study
    indicate</description>

    <dc:date>2012-01-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard/drugtopics/032012/756630null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>



